Article
10 Aug 2023
Medicare Drug Price Negotiation Program Final Guidance
AUTHORS CONTENT
Article
07 Aug 2023
Draft Cell And Gene Therapy Guidance Document Calls For Comparability And Lifecycle Management
Article
26 Jul 2023
Legal Battles Continue Over Inflation Reduction Act's Drug Price Negotiation Measures
Article
16 Jun 2023
What To Expect As IRA Legal Challenges Mount
Article
14 Jun 2023
Benefit Of Enhanced Diagnostic Test Oversight Touted By FDA
Article
12 Apr 2023
FDA Issues Final Transition Guidances For COVID-19 Devices
Article
05 Apr 2023
FDA Releases Draft Guidance For Labeling Of Plant-Based Milk Alternatives
Article
04 Apr 2023
CMS Announces Part B Prescription Drugs With Lower Coinsurance Amounts For Q2 2023
Article
31 Mar 2023
FDA Publishes Digital Health Technology Framework
Article
09 Feb 2023
Supreme Court Denies Review Of Cost Sharing Assistance Program
Article
01 Feb 2023
FTC Issues Updated Health Products Claims Guidance
Article
26 Jan 2023
FDA Updates COVID-19 Testing Guidances
Article
17 Jan 2023
Congress Expands FDA Authority Over Cosmetics
Article
16 Jan 2023
FDA Clarifies The Human Factors Or Usability Information To Include In A Device Marketing Submission
Article
15 Dec 2022
FDA Final Food Traceability Rule: Overview And Key Takeaways From FDA's Food Safety Modernization Act Webinar
Article
06 Dec 2022
The USPTO And The FDA Join Hands To Promote Competition
Article
24 Nov 2022
FDA Clears The Path To Lab-Grown Meat
Article
18 Nov 2022
FDA Clarifies ANDA Active Ingredient Sameness Evaluation In Draft Guidance
Article
17 Nov 2022
Prevent A Clinical Trial From Turning Into A Criminal Trial
Article
30 Sep 2022
FDA Updates COVID-19 Test Policy